The U.S. Justice Department’s criminal healthcare-fraud unit has opened an investigation into UnitedHealth Group’s Medicare Advantage billing practices, according to people familiar with the matter. Prosecutors are examining whether the company used doctors and nurses to collect diagnoses that boosted risk-adjusted payments from the federal program.

In recent weeks investigators from the Justice Department, the Federal Bureau of Investigation and the Department of Health and Human Services’ Office of Inspector General have questioned former UnitedHealth employees about how the insurer gathered and reported patient data, the Wall Street Journal reported.

UnitedHealth said a court-appointed Special Master previously concluded there was no evidence the company was overpaid or engaged in wrongdoing and cited Centers for Medicare & Medicaid Services audits showing its coding accuracy among the industry’s best.

The Journal’s report sent UnitedHealth shares down about 1% in pre-market trading on Wednesday.

The U.S. Supreme Court on Friday upheld a core provision of the Affordable Care Act that requires private insurers to cover certain preventive services at no cost to patients. In a 6–3 ruling written by Justice Brett Kavanaugh, the Court found that members of the U.S. Preventive Services Task Force are "inferior officers" who may be appointed by the Health and Human Services secretary without Senate confirmation, reversing a 2024 decision by the Fifth Circuit that had deemed the panel’s structure unconstitutional.

Read more

The U.S. Supreme Court ruled 6–3 that the structure of the U.S. Preventive Services Task Force complies with the Constitution’s Appointments Clause, preserving a central Affordable Care Act requirement that insurers cover certain preventive services without cost-sharing.

Writing for the majority in Kennedy v. Braidwood Management, Justice Brett Kavanaugh said the task force’s 16 volunteer experts remain under the supervision of the health and human services secretary—now Robert F. Kennedy Jr.—and therefore need not be appointed by the president and confirmed by the Senate. The decision reverses a 5th U.S. Circuit Court of Appeals ruling and keeps no-cost coverage for cancer screenings, statins, HIV pre-exposure prophylaxis and other services relied on by roughly 150 million insured Americans.

Read more

TMZ has released a documentary titled "TMZ Investigates: Luigi Mangione: The Mind of a Killer" on YouTube, exploring the background and motives of Luigi Mangione, who is accused of assassinating Brian Thompson, the CEO of UnitedHealthcare. The documentary delves into Mangione's transformation from a privileged individual to an alleged assassin, examining factors that may have driven him to commit the crime. It features interviews with two men who traveled with Mangione, providing insights into his character that challenge common perceptions. The film also investigates potential legal defenses Mangione might pursue, including the possibility of an insanity plea, despite substantial evidence against him.

Additionally, the documentary considers how Mangione's appearance and notoriety could influence jury bias during his trial. The case raises broader questions about societal issues such as wealth inequality and its potential role in violent acts against corporate leaders. The documentary has attracted attention alongside other crime-related media coverage, including a mention by PCMag referencing the backstory of the alleged shooter Luigi Mangione.

On June 23 and 24, 2025, more than 50 major U.S. health insurance companies, including UnitedHealthcare, CVS Health's Aetna, Cigna, and Blue Cross Blue Shield, pledged to streamline and expedite the prior authorization process, which often causes delays and complications in patient care. These insurers, representing about 75% of covered Americans—approximately 257 million people—committed to reducing the scope of health care claims requiring prior authorization and expanding real-time response capabilities. The initiative aims to cut red tape, improve coverage reviews, and make access to care quicker and less cumbersome.

The pledge was made under pressure from the Trump administration, with U.S. Health Secretary Kennedy receiving the commitment. Dr. Mehmet Oz publicly announced the insurers' promise to make prior authorization quicker and more efficient. The reforms include six key measures designed to simplify the process and address widespread complaints about delays and denials of care. Healthcare providers have expressed support for the voluntary reforms, and insurers aim to achieve real-time processing by 2027. Despite previous similar promises, this renewed effort highlights the industry's response to federal government and public demands for improved health care access.

Major U.S. health insurance companies, including UnitedHealthcare, CVS Health's Aetna, Cigna, and Blue Cross Blue Shield, have pledged to reform the prior authorization process to reduce delays and complications in patient care. This commitment affects approximately 257 million Americans, representing about 75% of those covered by health insurance. The insurers have agreed to scale back the scope of health care claims subject to prior authorization and aim to expand real-time responses.

These reforms are intended to streamline coverage reviews, which have been widely criticized for causing care delays and administrative burdens. The pledge comes amid pressure from the Trump administration and was publicly announced by Dr. Mehmet Oz. The insurers have committed to implementing six reforms designed to cut red tape and expedite access to care, with goals to achieve real-time processing by 2027. Federal health officials, including U.S. Health Secretary Kennedy, have promoted these insurer pledges as part of efforts to improve Medicare Advantage and Medicaid prior authorization procedures. Healthcare providers have expressed support for these voluntary reforms, which aim to make the prior authorization process quicker and less burdensome for patients and providers alike.

Republican lawmakers in Washington have rallied behind new legislation, the "One Big Beautiful Bill Act," that would impose work and other community-engagement requirements on certain able-bodied adults who receive Medicaid. The measure, championed by House Energy and Commerce Chairman Brett Guthrie and promoted by House and Senate GOP leaders, would require beneficiaries who are not working, studying or volunteering at least 80 hours a month to meet those thresholds to keep their coverage.

Read more

Shares of UnitedHealth Group Inc. (UNH) have declined below $300, reaching their cheapest valuation in recent history, with some investors predicting a further drop to $250. The company, traditionally known for delivering earnings beats despite limited transparency, now faces increased scrutiny from investors seeking more clarity, with some analysts recommending examining statutory data. Meanwhile, Lululemon Athletica Inc.

(LULU) hit a 52-week low, trading lower than levels seen when tariffs were first announced. The stock appears oversold amid several challenges including declining U.S. store traffic, deceleration in China, rising tariffs in Vietnam, increased competition in the Americas, and concerns over the financial impact and return on invested capital (ROIC) related to expanding store footprint. Despite these headwinds, Lululemon's management remains confident in its innovation strategy focused on women's apparel. Some market participants view the recent low as a potential interim bottom for Lululemon shares.

The Trump administration's tariffs, initially focused on consumer goods such as cars and iPhones, are now contributing to rising costs in the healthcare industry. Health insurers have warned state regulators that these tariffs are expected to drive up healthcare premiums in 2026, particularly in the individual and small group markets. This development highlights an expanding impact of trade policies beyond traditional consumer products, affecting healthcare pricing and insurance costs.

U.S. health insurers are beginning to cite President Donald Trump’s steep tariffs on Chinese imports as a reason for higher premiums, broadening the trade policy’s impact beyond the consumer-goods sector. Several carriers have told state regulators they will raise 2026 rates to offset expected increases in drug costs, according to an analysis published Monday by Matt McGough of the nonprofit Kaiser Family Foundation.

Read more

UnitedHealth Group Inc. is reducing commissions on about 200 Medicare Advantage plans as part of a broader push to trim costs and improve operating efficiency, according to market commentary on 18 June.

Investment advisers highlight the company’s renewed focus on capital discipline, pointing to a 9.6% free-cash-flow yield and an 8.6-times forward price-to-earnings multiple. UnitedHealth continues to generate earnings growth while looking for additional ways to curb spending.

The move follows renewed momentum in the stock. UnitedHealth shares climbed past $315 on 12 June amid heavy bullish options activity and were cited around $308 on 18 June, with some traders expecting a further advance toward the $320 level.

TMZ has released a series of investigative documentaries on YouTube exploring the deaths of several high-profile figures. Their special "TMZ Investigates: Who REALLY Killed Michael Jackson?" examines the circumstances surrounding the pop icon's death, revealing that 22 different medications, including massive doses of Demerol, were found at his bedside. The documentary features interviews with Michael Jackson's ex-wife Debbie Rowe and Dr. Conrad Murray, the doctor convicted of his death, who claims he was a scapegoat.

The investigation suggests multiple parties were ultimately responsible and scrutinizes the events leading up to Jackson's death, including the decision by AEG to proceed with the 'This Is It' tour despite his poor health. Separately, TMZ has also investigated the tragic death of singer Liam Payne, who died at age 31 after a fatal fall. Their special "TMZ Investigates: Liam Payne: Who's To Blame?" includes eyewitness accounts and questions the actions of hotel staff who reportedly forced an intoxicated Payne into his third-floor room shortly before his death. Additionally, Payne's final television appearance as a judge on Netflix's singing competition "Building the Band" has been highlighted in trailers and media coverage. Lastly, TMZ has released a documentary titled "TMZ Investigates: Luigi Mangione: The Mind of a Killer," exploring the motivations behind Luigi Mangione's assassination of UnitedHealthcare CEO Brian Thompson, including insights from Mangione's mother and new details about his breaking point leading to the killing.

Oregon Governor has signed Senate Bill 951 into law, reinstating stringent restrictions on private equity investments in medical practices and reaffirming prohibitions on the corporate practice of medicine. This legislative move follows a series of closures and bankruptcies among corporatized healthcare providers, including a UnitedHealth-owned practice, which highlighted the negative impact of corporate control on patient care and physician autonomy. Oregon State Representative Ben Bowman reintroduced the bill to make corporate medicine illegal again, aiming to ensure that physicians retain decision-making authority over healthcare. The law represents a rare legislative pushback against corporate healthcare models amid broader concerns about private equity's influence on healthcare costs and outcomes.

Concurrently, in Pennsylvania, lawmakers from Delaware County are pursuing regulations on private equity in healthcare following the closure of Crozer hospital. U.S. Representative Pramila Jayapal endorsed these efforts and called for federal legislation, specifically the Health Over Wealth Act, to address corporate control in healthcare. Additionally, Philadelphia City Council passed two housing bills affecting renters and landlords, and a bill to cap ticket reseller fees has advanced to the Pennsylvania Senate after bipartisan support in the state House.

Oregon Governor Tina Kotek has signed Senate Bill 951 into law, imposing stringent restrictions on private equity investments in medical practices. The legislation, described as one of the nation's most restrictive measures regulating the corporate practice of medicine, aims to protect the doctor-patient relationship by prioritizing patient care over financial interests. While the law is now in effect, discussions about potential amendments are already underway. The bill has received support from healthcare advocates who emphasize its role in maintaining accountability and focusing healthcare services on patient well-being.

UnitedHealthcare (UNH) has experienced notable market activity following its recent earnings report, which some investors describe as an overreaction given the company's earnings resilience. The stock has encountered technical resistance at the Monthly 3 level but showed a strong upward movement, with prices surpassing $314 and expectations of reaching above $320. Market participants are observing increased buying interest, potentially driven by fear of missing out (FOMO), although some investors are beginning to partially reduce their long positions around the $314 mark. Analysts and traders continue to monitor UNH's performance closely, with attention to technical indicators such as the 21-day exponential moving average (EMA).

Luigi Mangione, who has pleaded not guilty to the murder of UnitedHealthcare CEO Brian Thompson, has shared a list of 27 things he is grateful for after spending his 27th birthday in jail awaiting trial. Mangione has received over $1 million in donations from approximately 30,000 people to support his legal defense fund. His list of gratitude includes friends, family, talented individuals, letters, the mail room, memes, books, independent media creators, his cellmate, and jail staff. Despite the serious charges against him, Mangione has publicly reflected on positive aspects of his life while incarcerated.

UnitedHealth Group is seeking to sell Banmedica and its remaining Latin American businesses for as much as US$1 billion, according to people familiar with the process cited by Reuters. The disposal would mark the U.S. insurer’s full exit from the region as it concentrates resources on its domestic operations.

Four consortia have submitted non-binding offers, the sources said. The suitors are Brazilian private-equity firm Patria Investments, Peru-based healthcare operator Grupo Auna, U.S. non-profit Christus Health, and Washington-headquartered Acon Investments. The assets on the block include health-insurance and provider networks operating chiefly in South America.

UnitedHealth’s strategic review follows recent efforts to streamline its portfolio and sharpen its focus on the U.S. market, where the company generates the bulk of its revenue. A deal could be signed later this year if negotiations progress, the sources added, though terms remain subject to due diligence and regulatory approvals.

UnitedHealth Group and Humana have recently supported changes to Medicare Advantage home visit policies, agreeing to increased oversight of in-home payments. This comes amid reports that UnitedHealth's Medicare DisAdvantage plans have been paying nursing homes to deny necessary hospital care, prompting lawmakers including Representative Lloyd Doggett and Representative Alexandria Ocasio-Cortez to call for a Department of Justice investigation into potential fraud, waste, and abuse. An internal document from UnitedHealth, inadvertently shared with STAT News, suggested that most Americans' healthcare experiences are straightforward and that patients bear the costs, a statement criticized for downplaying systemic issues. Meanwhile, UnitedHealth Group faces a lawsuit from its own shareholders aimed at preventing the company from changing its corporate practices to approve more patient care, highlighting concerns that investor profits have been linked to high coverage denial rates.

Luigi Mangione, the suspect in the killing of UnitedHealthcare CEO Brian Thompson, kept a diary expressing his frustrations with the health insurance industry and his intent to carry out an attack. Prosecutors revealed that Mangione viewed Thompson and UnitedHealthcare as symbols of what he considered a greed-driven healthcare cartel. Court filings indicate Mangione surveilled Thompson the night before allegedly shooting him on a Manhattan street, initially considering a different target. Mangione stated his motive was to "prove a political point about the health insurance industry." His diary has become a central piece of evidence in the state case, where he faces charges including first-degree murder and murder as an act of terrorism.

UnitedHealthcare has filed a defamation lawsuit against The Guardian over a May 21 report alleging that the insurer secretly paid nursing homes to reduce hospital transfers and coerced residents into signing do-not-resuscitate orders as a cost-saving measure. The company accuses The Guardian of attempting to capitalize on the assassination of its then-CEO in its coverage. The report claimed that UnitedHealth paid bonuses to nursing homes to prevent hospital transfers and imposed these measures even when residents had expressed a desire for life-saving treatment. The lawsuit highlights ongoing tensions between UnitedHealthcare and media scrutiny related to its billing and care practices for nursing home residents.

The U.S. Justice Department’s criminal healthcare-fraud unit has opened an investigation into UnitedHealth Group’s Medicare Advantage billing practices, according to people familiar with the matter. Prosecutors are examining whether the company used doctors and nurses to collect diagnoses that boosted risk-adjusted payments from the federal program.

In recent weeks investigators from the Justice Department, the Federal Bureau of Investigation and the Department of Health and Human Services’ Office of Inspector General have questioned former UnitedHealth employees about how the insurer gathered and reported patient data, the Wall Street Journal reported.

UnitedHealth said a court-appointed Special Master previously concluded there was no evidence the company was overpaid or engaged in wrongdoing and cited Centers for Medicare & Medicaid Services audits showing its coding accuracy among the industry’s best.

The Journal’s report sent UnitedHealth shares down about 1% in pre-market trading on Wednesday.

The U.S. Supreme Court on Friday upheld a core provision of the Affordable Care Act that requires private insurers to cover certain preventive services at no cost to patients. In a 6–3 ruling written by Justice Brett Kavanaugh, the Court found that members of the U.S. Preventive Services Task Force are "inferior officers" who may be appointed by the Health and Human Services secretary without Senate confirmation, reversing a 2024 decision by the Fifth Circuit that had deemed the panel’s structure unconstitutional.

Read more

The U.S. Supreme Court ruled 6–3 that the structure of the U.S. Preventive Services Task Force complies with the Constitution’s Appointments Clause, preserving a central Affordable Care Act requirement that insurers cover certain preventive services without cost-sharing.

Writing for the majority in Kennedy v. Braidwood Management, Justice Brett Kavanaugh said the task force’s 16 volunteer experts remain under the supervision of the health and human services secretary—now Robert F. Kennedy Jr.—and therefore need not be appointed by the president and confirmed by the Senate. The decision reverses a 5th U.S. Circuit Court of Appeals ruling and keeps no-cost coverage for cancer screenings, statins, HIV pre-exposure prophylaxis and other services relied on by roughly 150 million insured Americans.

Read more

TMZ has released a documentary titled "TMZ Investigates: Luigi Mangione: The Mind of a Killer" on YouTube, exploring the background and motives of Luigi Mangione, who is accused of assassinating Brian Thompson, the CEO of UnitedHealthcare. The documentary delves into Mangione's transformation from a privileged individual to an alleged assassin, examining factors that may have driven him to commit the crime. It features interviews with two men who traveled with Mangione, providing insights into his character that challenge common perceptions. The film also investigates potential legal defenses Mangione might pursue, including the possibility of an insanity plea, despite substantial evidence against him.

Additionally, the documentary considers how Mangione's appearance and notoriety could influence jury bias during his trial. The case raises broader questions about societal issues such as wealth inequality and its potential role in violent acts against corporate leaders. The documentary has attracted attention alongside other crime-related media coverage, including a mention by PCMag referencing the backstory of the alleged shooter Luigi Mangione.

On June 23 and 24, 2025, more than 50 major U.S. health insurance companies, including UnitedHealthcare, CVS Health's Aetna, Cigna, and Blue Cross Blue Shield, pledged to streamline and expedite the prior authorization process, which often causes delays and complications in patient care. These insurers, representing about 75% of covered Americans—approximately 257 million people—committed to reducing the scope of health care claims requiring prior authorization and expanding real-time response capabilities. The initiative aims to cut red tape, improve coverage reviews, and make access to care quicker and less cumbersome.

The pledge was made under pressure from the Trump administration, with U.S. Health Secretary Kennedy receiving the commitment. Dr. Mehmet Oz publicly announced the insurers' promise to make prior authorization quicker and more efficient. The reforms include six key measures designed to simplify the process and address widespread complaints about delays and denials of care. Healthcare providers have expressed support for the voluntary reforms, and insurers aim to achieve real-time processing by 2027. Despite previous similar promises, this renewed effort highlights the industry's response to federal government and public demands for improved health care access.

Major U.S. health insurance companies, including UnitedHealthcare, CVS Health's Aetna, Cigna, and Blue Cross Blue Shield, have pledged to reform the prior authorization process to reduce delays and complications in patient care. This commitment affects approximately 257 million Americans, representing about 75% of those covered by health insurance. The insurers have agreed to scale back the scope of health care claims subject to prior authorization and aim to expand real-time responses.

These reforms are intended to streamline coverage reviews, which have been widely criticized for causing care delays and administrative burdens. The pledge comes amid pressure from the Trump administration and was publicly announced by Dr. Mehmet Oz. The insurers have committed to implementing six reforms designed to cut red tape and expedite access to care, with goals to achieve real-time processing by 2027. Federal health officials, including U.S. Health Secretary Kennedy, have promoted these insurer pledges as part of efforts to improve Medicare Advantage and Medicaid prior authorization procedures. Healthcare providers have expressed support for these voluntary reforms, which aim to make the prior authorization process quicker and less burdensome for patients and providers alike.

Republican lawmakers in Washington have rallied behind new legislation, the "One Big Beautiful Bill Act," that would impose work and other community-engagement requirements on certain able-bodied adults who receive Medicaid. The measure, championed by House Energy and Commerce Chairman Brett Guthrie and promoted by House and Senate GOP leaders, would require beneficiaries who are not working, studying or volunteering at least 80 hours a month to meet those thresholds to keep their coverage.

Read more

Shares of UnitedHealth Group Inc. (UNH) have declined below $300, reaching their cheapest valuation in recent history, with some investors predicting a further drop to $250. The company, traditionally known for delivering earnings beats despite limited transparency, now faces increased scrutiny from investors seeking more clarity, with some analysts recommending examining statutory data. Meanwhile, Lululemon Athletica Inc.

(LULU) hit a 52-week low, trading lower than levels seen when tariffs were first announced. The stock appears oversold amid several challenges including declining U.S. store traffic, deceleration in China, rising tariffs in Vietnam, increased competition in the Americas, and concerns over the financial impact and return on invested capital (ROIC) related to expanding store footprint. Despite these headwinds, Lululemon's management remains confident in its innovation strategy focused on women's apparel. Some market participants view the recent low as a potential interim bottom for Lululemon shares.

The Trump administration's tariffs, initially focused on consumer goods such as cars and iPhones, are now contributing to rising costs in the healthcare industry. Health insurers have warned state regulators that these tariffs are expected to drive up healthcare premiums in 2026, particularly in the individual and small group markets. This development highlights an expanding impact of trade policies beyond traditional consumer products, affecting healthcare pricing and insurance costs.

U.S. health insurers are beginning to cite President Donald Trump’s steep tariffs on Chinese imports as a reason for higher premiums, broadening the trade policy’s impact beyond the consumer-goods sector. Several carriers have told state regulators they will raise 2026 rates to offset expected increases in drug costs, according to an analysis published Monday by Matt McGough of the nonprofit Kaiser Family Foundation.

Read more

UnitedHealth Group Inc. is reducing commissions on about 200 Medicare Advantage plans as part of a broader push to trim costs and improve operating efficiency, according to market commentary on 18 June.

Investment advisers highlight the company’s renewed focus on capital discipline, pointing to a 9.6% free-cash-flow yield and an 8.6-times forward price-to-earnings multiple. UnitedHealth continues to generate earnings growth while looking for additional ways to curb spending.

The move follows renewed momentum in the stock. UnitedHealth shares climbed past $315 on 12 June amid heavy bullish options activity and were cited around $308 on 18 June, with some traders expecting a further advance toward the $320 level.

TMZ has released a series of investigative documentaries on YouTube exploring the deaths of several high-profile figures. Their special "TMZ Investigates: Who REALLY Killed Michael Jackson?" examines the circumstances surrounding the pop icon's death, revealing that 22 different medications, including massive doses of Demerol, were found at his bedside. The documentary features interviews with Michael Jackson's ex-wife Debbie Rowe and Dr. Conrad Murray, the doctor convicted of his death, who claims he was a scapegoat.

The investigation suggests multiple parties were ultimately responsible and scrutinizes the events leading up to Jackson's death, including the decision by AEG to proceed with the 'This Is It' tour despite his poor health. Separately, TMZ has also investigated the tragic death of singer Liam Payne, who died at age 31 after a fatal fall. Their special "TMZ Investigates: Liam Payne: Who's To Blame?" includes eyewitness accounts and questions the actions of hotel staff who reportedly forced an intoxicated Payne into his third-floor room shortly before his death. Additionally, Payne's final television appearance as a judge on Netflix's singing competition "Building the Band" has been highlighted in trailers and media coverage. Lastly, TMZ has released a documentary titled "TMZ Investigates: Luigi Mangione: The Mind of a Killer," exploring the motivations behind Luigi Mangione's assassination of UnitedHealthcare CEO Brian Thompson, including insights from Mangione's mother and new details about his breaking point leading to the killing.

Oregon Governor has signed Senate Bill 951 into law, reinstating stringent restrictions on private equity investments in medical practices and reaffirming prohibitions on the corporate practice of medicine. This legislative move follows a series of closures and bankruptcies among corporatized healthcare providers, including a UnitedHealth-owned practice, which highlighted the negative impact of corporate control on patient care and physician autonomy. Oregon State Representative Ben Bowman reintroduced the bill to make corporate medicine illegal again, aiming to ensure that physicians retain decision-making authority over healthcare. The law represents a rare legislative pushback against corporate healthcare models amid broader concerns about private equity's influence on healthcare costs and outcomes.

Concurrently, in Pennsylvania, lawmakers from Delaware County are pursuing regulations on private equity in healthcare following the closure of Crozer hospital. U.S. Representative Pramila Jayapal endorsed these efforts and called for federal legislation, specifically the Health Over Wealth Act, to address corporate control in healthcare. Additionally, Philadelphia City Council passed two housing bills affecting renters and landlords, and a bill to cap ticket reseller fees has advanced to the Pennsylvania Senate after bipartisan support in the state House.

Oregon Governor Tina Kotek has signed Senate Bill 951 into law, imposing stringent restrictions on private equity investments in medical practices. The legislation, described as one of the nation's most restrictive measures regulating the corporate practice of medicine, aims to protect the doctor-patient relationship by prioritizing patient care over financial interests. While the law is now in effect, discussions about potential amendments are already underway. The bill has received support from healthcare advocates who emphasize its role in maintaining accountability and focusing healthcare services on patient well-being.

UnitedHealthcare (UNH) has experienced notable market activity following its recent earnings report, which some investors describe as an overreaction given the company's earnings resilience. The stock has encountered technical resistance at the Monthly 3 level but showed a strong upward movement, with prices surpassing $314 and expectations of reaching above $320. Market participants are observing increased buying interest, potentially driven by fear of missing out (FOMO), although some investors are beginning to partially reduce their long positions around the $314 mark. Analysts and traders continue to monitor UNH's performance closely, with attention to technical indicators such as the 21-day exponential moving average (EMA).

Luigi Mangione, who has pleaded not guilty to the murder of UnitedHealthcare CEO Brian Thompson, has shared a list of 27 things he is grateful for after spending his 27th birthday in jail awaiting trial. Mangione has received over $1 million in donations from approximately 30,000 people to support his legal defense fund. His list of gratitude includes friends, family, talented individuals, letters, the mail room, memes, books, independent media creators, his cellmate, and jail staff. Despite the serious charges against him, Mangione has publicly reflected on positive aspects of his life while incarcerated.

UnitedHealth Group is seeking to sell Banmedica and its remaining Latin American businesses for as much as US$1 billion, according to people familiar with the process cited by Reuters. The disposal would mark the U.S. insurer’s full exit from the region as it concentrates resources on its domestic operations.

Four consortia have submitted non-binding offers, the sources said. The suitors are Brazilian private-equity firm Patria Investments, Peru-based healthcare operator Grupo Auna, U.S. non-profit Christus Health, and Washington-headquartered Acon Investments. The assets on the block include health-insurance and provider networks operating chiefly in South America.

UnitedHealth’s strategic review follows recent efforts to streamline its portfolio and sharpen its focus on the U.S. market, where the company generates the bulk of its revenue. A deal could be signed later this year if negotiations progress, the sources added, though terms remain subject to due diligence and regulatory approvals.

UnitedHealth Group and Humana have recently supported changes to Medicare Advantage home visit policies, agreeing to increased oversight of in-home payments. This comes amid reports that UnitedHealth's Medicare DisAdvantage plans have been paying nursing homes to deny necessary hospital care, prompting lawmakers including Representative Lloyd Doggett and Representative Alexandria Ocasio-Cortez to call for a Department of Justice investigation into potential fraud, waste, and abuse. An internal document from UnitedHealth, inadvertently shared with STAT News, suggested that most Americans' healthcare experiences are straightforward and that patients bear the costs, a statement criticized for downplaying systemic issues. Meanwhile, UnitedHealth Group faces a lawsuit from its own shareholders aimed at preventing the company from changing its corporate practices to approve more patient care, highlighting concerns that investor profits have been linked to high coverage denial rates.

Luigi Mangione, the suspect in the killing of UnitedHealthcare CEO Brian Thompson, kept a diary expressing his frustrations with the health insurance industry and his intent to carry out an attack. Prosecutors revealed that Mangione viewed Thompson and UnitedHealthcare as symbols of what he considered a greed-driven healthcare cartel. Court filings indicate Mangione surveilled Thompson the night before allegedly shooting him on a Manhattan street, initially considering a different target. Mangione stated his motive was to "prove a political point about the health insurance industry." His diary has become a central piece of evidence in the state case, where he faces charges including first-degree murder and murder as an act of terrorism.

UnitedHealthcare has filed a defamation lawsuit against The Guardian over a May 21 report alleging that the insurer secretly paid nursing homes to reduce hospital transfers and coerced residents into signing do-not-resuscitate orders as a cost-saving measure. The company accuses The Guardian of attempting to capitalize on the assassination of its then-CEO in its coverage. The report claimed that UnitedHealth paid bonuses to nursing homes to prevent hospital transfers and imposed these measures even when residents had expressed a desire for life-saving treatment. The lawsuit highlights ongoing tensions between UnitedHealthcare and media scrutiny related to its billing and care practices for nursing home residents.